Advances in Cancer Immunotherapy™: A Focus on Biomarkers

When:  Mar 24, 2022 from 16:00 to 20:15 (PT)
This will be a hybrid program.


(Nora) Mary L. Disis, MD, FACP – University of Washington
Andrew Coveler, MD – University of Washington/Fred Hutchinson Cancer Research Center

Program Learning Objectives 

  • Discuss biomarkers in clinical use with approved cancer immunotherapies.
  • Summarize recent updates in the use of biomarkers for cancer immunotherapies.
  • Implement the use of biomarkers to select appropriate treatments for patients with cancer.

For more information on the program, click below.


View the SITC Meeting Code of Conduct.


Seattle Marriott Waterfront
2100 Alaskan Way
Room - Grand Pacific D
Seattle, WA 98121